Intra-cellular Therapies Surges to 340th in Daily Rankings with 2.46 Billion Turnover

On March 27, 2025, Intra-cellular Therapies (ITCI) saw a significant increase in trading volume, with a turnover of 2.46 billion, marking an 83.66% rise from the previous day. This surge placed Intra-cellular Therapies at the 340th position in the daily stock market rankings. The stock price of Intra-cellular Therapies (ITCI) rose by 0.05%.

Intra-Cellular Therapies has outperformed 72% of the companies evaluated by MarketBeat, securing the 261st position out of 940 stocks in the medical sector. This ranking highlights the company's strong performance and market standing within the industry.

Intra-Cellular Therapies, Inc. recently reached an all-time high stock price of $131.79, reflecting the company's robust financial health and investor confidence. This milestone underscores the company's continued growth and success in the medical sector.